5 reports

  • DRUG OVERDOSE - PIPELINE BY CROSSJECT SA, H1 2018
  • DRUG OVERDOSE - PIPELINE BY ADAPT PHARMA LTD, H1 2018

The molecules developed by Companies in Pre-Registration, Phase I, IND/ CTA Filed, Preclinical, Discovery and Unknown stages are ##, ##, ##, ##, ## and ## respectively.

  • Opioid
  • Pharmaceutical
  • United States
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • Drug Overdose - Pipeline by Fab'entech SA, H2 2017
  • Drug Overdose - Pipeline by Insys Therapeutics Inc, H2 2017

The molecules developed by Companies in Pre-Registration, Phase III, Phase I, IND/ CTA Filed, Preclinical and Discovery stages are ##, ##, ##, ##, ## and ## respectively.

  • Opioid
  • United States
  • Company
  • Product Initiative
  • Opiant Pharmaceuticals, Inc.
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY CAMURUS AB, H1 2018
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY FAB'ENTECH SA, H1 2018

## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery ## ## Unknown ## ## Total ## ## Products in Phase II/ III and I/ II are reflected under Phase III and Phase II, respectively Source: Global Markets Direct NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPIU

  • Opioid
  • Therapy
  • United States
  • Product Initiative
  • Addex Therapeutics Ltd
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY CAMURUS AB, H2 2017
  • OPIUM (OPIOID) ADDICTION - PIPELINE BY FAB'ENTECH SA, H2 2017

It offers products for the treatment of H##N## avian influenza virus, ebola, crimean-congo hemorrhagic fever, Middle East respiratory syndrome coronavirus, nipah and hendra viruses, lassa, marburg, yellow fever, dengue, Japanese encephalitis and other emerging diseases.

  • Opioid
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Clinical Trial
  • Drug Discovery And Development
  • Opioid
  • Pharmaceutical
  • World